• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1125300-38
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 09/01/2021
Event Type  Injury  
Event Description
It was reported through a research article that a non-abbott stent was implanted in the left circumflex artery, but protruded into the left main artery.One month later, during implantation of a 3.0x38mm xience alpine stent in the left main artery to the anterior descending coronary artery, it was noted that the wall apposition was poor around the area of the previously implanted non-abbott stent.At the area of malapposition, thrombus was noted.Treatment is unknown.For complete reported information, please see the attached article, titled ¿napkin ring formation in culotte stenting using current-generation drug-eluting stents in left main coronary artery bifurcation.".
 
Manufacturer Narrative
Date of event ¿ estimated.Treatment/therapy start date - estimated.Date of implant ¿ estimated.The device was not returned for evaluation.A review of the lot history record and complaint history of the reported lot could not be conducted because the lot number was not provided.The reported patient effect of thrombosis/thrombus is listed in the xience alpine everolimus eluting coronary stent systems instructions for use (ifu) as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient-device incompatibility, thrombosis/thrombus, and serious injury/ illness/ impairment, and their relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Attached article, titled ¿napkin ring formation in culotte stenting using current-generation drug-eluting stents in left main coronary artery bifurcation.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14881840
MDR Text Key295114479
Report Number2024168-2022-07125
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648199394
UDI-Public08717648199394
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 06/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1125300-38
Device Catalogue Number1125300-38
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age64 YR
Patient SexMale
-
-